The University of Chicago
Department of Medicine
Virtual Grand Rounds
Rita Nanda, MD
Associate Professor of Medicine
Director of Breast Oncology
Section of Hematology/Oncology
“The Emerging Role of Immunotherapy for Triple-Negative Breast Cancer”
Learning objectives: To define the role of immune checkpoint inhibitors in advanced and early-stage triple-negative breast cancer.
To describe immune-related adverse events associated with immune checkpoint inhibitor therapy in early stage breast cancer.
Contact Shanda Lentz for Zoom link.
September 21, 2021
12:00pm - 1:00pm